Twitter | Search | |
Bryan D Hayes PharmD
Emergency Medicine Pharmacist & Toxicologist | Assistant Professor | Past-President ABAT | EIC | Views own
3,642
Tweets
138
Following
17,419
Followers
Tweets
Bryan D Hayes PharmD Sep 25
FDA issues warning about the "Benadryl Challenge" For anticholinergic poisoning, here is Pearl 12 from our EM Pharmacology Educational Series archive, 'Don't Fear Physostigmine'
Reply Retweet Like
Bryan D Hayes PharmD Sep 23
Extracorporeal removal not recommended for hydroxychloroquine, chloroquine, or quinine overdose.
Reply Retweet Like
Bryan D Hayes PharmD Sep 23
Replying to @sameerucla
And, here's a summary of the ED droperidol studies since the AAEM position statement was published. /end
Reply Retweet Like
Bryan D Hayes PharmD Sep 23
Replying to @sameerucla @aaeminfo
Something you can use for evidence is the 2015 Position Statement on Safety of Droperidol Use in the ED 3/
Reply Retweet Like
Bryan D Hayes PharmD Sep 23
Replying to @sameerucla
One of the talks I give is "Black Box Drugs We Use in the ED." Here's the handout which includes info on droperidol: 2/
Reply Retweet Like
Bryan D Hayes PharmD Sep 23
Replying to @sameerucla
The droperidol boxed warning suggestion for monitoring applies to "patients in whom the potential benefit of droperidol treatment is felt to outweigh the risks of potentially serious arrhythmias" 1/
Reply Retweet Like
Bryan D Hayes PharmD Sep 19
5 Medication Pearls for Atrial Fibrillation Management in the ED Pearl 42 from our EM Pharmacology Educational Series
Reply Retweet Like
Bryan D Hayes PharmD Sep 16
Thanks! This wasn’t my original idea, but it’s a great trick-of-the-trade. We use this approach often in the ED. Here’s the post on ‘Naloxone Dilution for Opioid Overdose.’
Reply Retweet Like
Bryan D Hayes PharmD Sep 15
We discussed this nuanced topic of 'Treat & Release After Naloxone' on including studies up through 2019. Fellow toxicologist provided some insightful commentary/expert review. Bottom line: It's complicated and difficult to study.
Reply Retweet Like
Bryan D Hayes PharmD Sep 12
Officially passed the gavel today at as I finished my 2-year term as President of the American Board of Applied Toxicology (ABAT). It was an honor to serve and I'm extremely proud of all we accomplished together.
Reply Retweet Like
Bryan D Hayes PharmD Sep 11
Boston was hit hard. These are the heroes I work with. Featured by as the Wonder Women they are.
Reply Retweet Like
Bryan D Hayes PharmD Sep 10
The CEO of (largest hospital pharmacist organization) responds to the EMRA Joint Statement, urging the co-signers to "reconsider the broad brush with which they painted non-physician residents and other learners."
Reply Retweet Like
Bryan D Hayes PharmD Sep 6
Replying to @CardiacPA1
Agree. Problem is that AAEM, one of the co-signers of this new joint statement has a pretty expansive list of what they consider APPs (including pharmacists).
Reply Retweet Like
Bryan D Hayes PharmD Sep 6
Replying to @ApparentLiMD
This does apply to PharmDs because AAEM includes them with all other APPs and is one of the co-signers of this statement. Pharmacists have had EM residencies for decades.
Reply Retweet Like
Bryan D Hayes PharmD Sep 5
Replying to @cjosephy
I agree 100% with you, but unfortunately, AAEM includes PharmDs along with other APPs:
Reply Retweet Like
Bryan D Hayes PharmD Sep 5
Replying to @PharmERToxGuy
Final thought: Though this joint statement was not (necessarily) intended for PharmDs, it certainly will affect them and was written without collaboration from this important allied-health component of the EM care team. I agree that words do matter. /end
Reply Retweet Like
Bryan D Hayes PharmD Sep 5
Replying to @emresidents
Nationally, EM PharmDs teach at EM conferences, co-author EM white papers/position statements, and serve on EM committees. Flip through the guides (eg, Pain Management, Antibiotic, PressorDex) and count how many PharmDs are editors. 13/
Reply Retweet Like
Bryan D Hayes PharmD Sep 5
Guidelines on Emergency Medicine Pharmacist Services are published and updated by (most recently in 2020): 12/
Reply Retweet Like
Bryan D Hayes PharmD Sep 5
Replying to @ACEPNow @acmtmedtox
Two major, national medical organizations published position statements on the role of the EM pharmacist: in 2015: in 2018: 11/
Reply Retweet Like
Bryan D Hayes PharmD Sep 5
We have a PharmD on the faculty in the Department of EM, highlighting the integral role they play in education. We also contribute significantly to the toxicology rotation in collaboration with . 10/
Reply Retweet Like